Serum protein binding of propofol in critically ill patients

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 10, 1997, Pages 1267-1272

  Zamacona, M K ^a   Suarez E ^a   Aguilera, L ^b   Rodriguez Sasiain J M ^a   Aguirre, C ^a   Calvo, R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Critically ill patients; Propofol; Serum protein binding

Indexed keywords

ANESTHETIC AGENT; OROSOMUCOID; PROPOFOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG PROTEIN BINDING; FEMALE; HUMAN; MALE; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REGRESSION ANALYSIS; ULTRAFILTRATION; VOLUNTEER;

EID: 0030666940     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04643.x     Document Type: Article

References (27)

1. Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology 1994: 81: 1005-1043.
2. McCleane GJ, Fogarty DF, Watters CH. Factors that influence the induction dose of propofol. Anaesthesia 1991: 46: 59-61.
3. Ghoneim MM, Pandya H. Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 1975: 42: 545-549.
4. Halliday NJ, Dundee JW, Loughram PG, Harper KW. Age and plasma proteins influence the action of midazolam. Anesthesiology 1985: 62: 712-724.
5. Cockshott ID, Douglas EJ, Plummer GF, Simons PJ. The pharmacokinetics of propofol in laboratory animals. Xenobiotica 1992: 50: 636-657.
6. Teh J, Short TG, Wong J, Tan P. Pharmacokinetic interactions between midazolam and propofol: an infusion study. Br J Anaesth 1994: 72: 62-65.
7. Garrido MJ, Jiménez RM, Rodriguez-Sasiaín JM, Aguirre C, Aguilera L, Calvo R. Characterization of the protein binding of propofol and its possible interactions. Rev Esp Anest Reanimación 1994: 41: 308-312. (Spanish with an English abstract).
8. Costela JL, Jiménez R, Calvo R, Suárez E, Carlos R. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 1996: 40: 741-745.
9. Kirvelä M, Olkkola KT, Rosenberg PH, Yli-Hankala A, Salmela K, Lindgren L. Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. Br J Anaesth 1992: 68: 178-182.
10. Nathan N, Debord J, Narcisse F, Dupuis M, Lagarde M, Benevent D et al. Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study. Acta Anaesth Belg 1993: 44: 77-85.
11. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988: 69: 887-891.
12. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995: 50: 636-657.
13. Newman LH, McDonald JC, Wallace PGM, Ledinghan IM. Propofol infusion for sedation in intensive care. Anaesthesia 1987: 42: 929-937.
14. Park GR. Pharmacokinetics and pharmacodynamics in the critically ill patient. Xenobiotica 1993: 20: 1195-1230.
15. McCluskey A, Thomas AN, Bowles BJM, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 1996: 51: 724-727.
16. Zielmann S, Mielck F, Kahl R, Kazmaie S, Sydow M, Kolk J et al. A rational basis for the measurement of free phenytoin concentration in critically ill trauma patients. Ther Drug Monit 1994: 16: 139-144.
17. Anderson GD, Gidal BE, Hendryx RJ, Awan AB, Temkin NR, Wilensky AJ et al. Decreased plasma protein binding of valproate in patients with acute head trauma. Br J Clin Pharmacol 1994: 37: 559-562.
18. March C, Blanke RV. Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 ultrafiltrarion System. Ther Drug Monit 1985: 7: 115-120.
19. Chan K, So APC. The measurement of propofol in human blood samples by liquid chromatography. Methods Find Exp Clin Pharmacol 1990: 12: 135-139.
20. Carlos R, Calvo R, Erill S. Plasma protein binding of etomidate in patients with renal failure or hepatic cirrhosis. Clin Pharmacokinet 1979: 4: 144-148.
21. Vinik HR, Reves JG, Hixon D, Welchel J, McFarland L. Midazolam induction and emergence in renal failure patients. Anesthesiology 1981: A262.
22. Lindow J, Wijdicks EFM. Phenytoin toxicity associated with hypoalbuminemia in critically ill patients. Chest 1994: 105: 602-604.
23. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of Propofol (Diprivan) in elderly patients. Br J Anaesth 1988: 60: 146-150.
24. Bailie GR, Cockshott E, Douglas EJ, Bowles BJM. Pharmacokinetics of propofol during and after long term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth 1992: 68: 486-491.
25. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: recovery and blood concentrations changes during periodic interruptions in infusion. Br J Anaesth 1988: 61: 583-588.
26. Vree TB, Shimoda M, Driessen JJ, Gueler PJM, Janssen TJ, Termond EFS et al. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clin Pharmacol Ther 1989: 46: 537-544.
27. Gidal BE, Collins M, Beinlich BR. Apparent valproic acid neurotoxicity in a hypoalbuminemic patient. Ann Pharmacother 1993: 27: 32-35.